# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Factor VIII deficiency

Hemophilia AClassic hemophilia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 110 results.
Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT®
Status: Recruiting
Last Changed: Nov 27, 2018
First Received: Dec 30, 2016
Disease(s): Hemophilia A, Hemophilia, Factor VIII Deficiency
Intervention(s): Octocog Alfa
Locations: Complexo Hospitalario Universitario A Coruña, A Coruna, A Coruña, Spain
Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
Hospital Sant Joan de Deu, Esplugues de Llobregat, Barcelona, Spain
Hospital Universitario Son Espases, Palma, Islas Baleares, Spain
Hospital Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain
... and 10 other locations.
Factor VIII Gene Therapy Study in Patients With Hemophilia A
Status: Recruiting
Last Changed: Aug 16, 2019
First Received: Jul 17, 2018
Disease(s): Hemophilia A
Intervention(s): BAY2599023 (DTX201)
Locations: Arkansas Children's Hospital, Little Rock, Arkansas, United States
Loma Linda Children's Hospital, San Bernardino, California, United States
C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
University of Wisconsin - Madison, Madison, Wisconsin, United States
... and 21 other locations.
Drug Use Investigation of Kovaltry in Hemophilia A Patients
Status: Recruiting
Last Changed: Jul 30, 2019
First Received: Oct 21, 2016
Disease(s): Hemophilia A
Intervention(s): Kovaltry (Antihemophilic Factor [Recombinant], BAY81-8973)
Locations: Many Locations, Multiple Locations, Japan
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg
Status: Recruiting
Last Changed: May 30, 2019
First Received: Jan 08, 2018
Disease(s): Hemophilia A
Intervention(s): Valoctocogene Roxaparvovec
Locations: UC Davis Hemophilia Treatment Center, Sacramento, California, United States
University of California San Diego, San Diego, California, United States
UCSF Medical Center, San Francisco, California, United States
University of Colorado AMC, Hemophilia and Thrombosis Center, Aurora, Colorado, United States
UF Shands Cancer Center, Gainesville, Florida, United States
... and 64 other locations.
Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A
Status: Not yet recruiting
Last Changed: Jul 04, 2019
First Received: Jan 28, 2019
Disease(s): Hemophilia A
Intervention(s): Auto CD34+PBSC, transduced with a lentiviral vector encoding the B domain deleted from of human coagulation factor VIII
Safety and Pharmacokinetics of Subcutaneous Injection of OCTA101 in Adult Patients With Severe Hemophilia A
Status: Recruiting
Last Changed: Aug 06, 2019
First Received: Aug 06, 2019
Disease(s): Severe Hemophilia A
Intervention(s): OCTA101
Locations: Specialized Hospital for Active Treatment of Hematological Diseases EAD Clinic of Clinical Hematology, Sofia, Bulgaria
A Gene Transfer Study for Hemophilia A
Status: Recruiting
Last Changed: Mar 13, 2019
First Received: Dec 28, 2016
Disease(s): Hemophilia A
Intervention(s): SPK-8011
Locations: University of California Davis - Hemostasis and Thrombosis Center, Sacramento, California, United States
Boston Children's Hospital, Boston, Massachusetts, United States
Mississippi Center for Advanced Medicine, Madison, Mississippi, United States
Weill Cornell Medicine-Comprehensive Center for Hemophilia and Coagulation Disorders, New York, New York, United States
East Carolina University, Greenville, North Carolina, United States
... and 7 other locations.
Exercise Versus DDAVP in Patients With Mild Hemophilia A
Status: Recruiting
Last Changed: Oct 02, 2018
First Received: Dec 20, 2017
Disease(s): Hemophilia A
Intervention(s): DDAVP Inhalant Product, Exercise Intervention
Locations: Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana, United States
Akron Children's Hospital, Akron, Ohio, United States
Nationwide Children's Hospital, Columbus, Ohio, United States
Dayton Children's Hospital, Dayton, Ohio, United States
Study to Compare How the Body Distributes and Excretes the Drugs Jivi (BAY 94-9027) and Adynovi in Patients With Severe Hemophilia A (Bleeding Disorder Resulting From a Lack of Blood Clotting Factor VIII)
Status: Not yet recruiting
Last Changed: Aug 09, 2019
First Received: Jul 11, 2019
Disease(s): Hemophilia A
Intervention(s): Damoctocog-alfa-pegol (BAY94-9027, Jivi), Rurioctocog alfa pegol (Adynovi)
Locations: SHATHD Spec. Hospi. for Active Treatm. of Haematol. Dis. EAD, Sofia, Bulgaria
Gene Therapy for Haemophilia A.
Status: Recruiting
Last Changed: Feb 20, 2018
First Received: Dec 23, 2016
Disease(s): Hemophilia A
Intervention(s): AAV2/8-HLP-FVIII-V3
Locations: St Jude's Children's Research Hospital, Memphis, Tennessee, United States
Royal Free Hospital, London, United Kingdom